| editorial | Q871232 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047651756 |
| P356 | DOI | 10.1038/EYE.2014.135 |
| P932 | PMC publication ID | 4094808 |
| P698 | PubMed publication ID | 25008575 |
| P5875 | ResearchGate publication ID | 263861817 |
| P50 | author | Augusto Azuara-Blanco | Q55113218 |
| Paul J Foster | Q56264704 | ||
| Naomi Fulop | Q56840075 | ||
| Christos Vasilakis | Q56983029 | ||
| Martin Utley | Q37835173 | ||
| P2093 | author name string | A Kotecha | |
| S Turner | |||
| P2860 | cites work | Patient pathways for macular disease: what will the new optometrist with special interest achieve? | Q79241954 |
| What value do consultant nurses place on the the White Paper, Our Health, Our Care, Our Say: a New Direction For Community Services (DH 2006A)? | Q80030182 | ||
| Doctors, managers and the battle for quality | Q81555643 | ||
| Modelling the prevalence of age-related macular degeneration (2010-2020) in the UK: expected impact of anti-vascular endothelial growth factor (VEGF) therapy | Q83403021 | ||
| A mobile eye unit for screening of diabetic retinopathy and follow-up of glaucoma in remote locations in northern Finland | Q83976762 | ||
| Prevalence of diabetic macular oedema and related health and social care resource use in England | Q84165023 | ||
| Doctors and managers. "You just don't understand" | Q95810392 | ||
| The number of people with glaucoma worldwide in 2010 and 2020 | Q24679554 | ||
| A qualitative investigation into patients' views on visual field testing for glaucoma monitoring | Q30568787 | ||
| Facilitators and barriers to implementing clinical care pathways | Q33618381 | ||
| The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom. | Q33855388 | ||
| Explaining Michigan: developing an ex post theory of a quality improvement program | Q35124334 | ||
| A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy | Q35180490 | ||
| Economic implications of increased longevity in the United States | Q35688823 | ||
| Action on AMD. Optimising patient management: act now to ensure current and continual delivery of best possible patient care | Q35797079 | ||
| Shared care of patients with ocular hypertension in the Community and Hospital Allied Network Glaucoma Evaluation Scheme (CHANGES). | Q35886798 | ||
| The effect of appointment rescheduling on monitoring interval and patient attendance in the glaucoma outpatient clinic | Q35955582 | ||
| The Portsmouth-based glaucoma refinement scheme: a role for virtual clinics in the future? | Q36316054 | ||
| Innovations in major system reconfiguration in England: a study of the effectiveness, acceptability and processes of implementation of two models of stroke care | Q36535536 | ||
| Shifting care from hospitals to the community: a review of the evidence on quality and efficiency | Q36779778 | ||
| A survey of attitudes of glaucoma subspecialists in England and Wales to visual field test intervals in relation to NICE guidelines | Q36821737 | ||
| The effectiveness of schemes that refine referrals between primary and secondary care--the UK experience with glaucoma referrals: the Health Innovation & Education Cluster (HIEC) Glaucoma Pathways Project. | Q37029910 | ||
| Is follow-up capacity the current NHS bottleneck? | Q37853135 | ||
| NICE - impact on glaucoma case detection | Q37872337 | ||
| Comparison of the effectiveness of two enhanced glaucoma referral schemes | Q37880183 | ||
| Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: a literature review | Q38127625 | ||
| Virtual outreach: economic evaluation of joint teleconsultations for patients referred by their general practitioner for a specialist opinion | Q39097725 | ||
| The use of teleglaucoma at the University of Alberta | Q39122822 | ||
| Ophthalmologists and optometrists--interesting times? | Q40700560 | ||
| Doctors and managers. Agreeing objectives could help doctors and managers work well together | Q41822979 | ||
| Challenges of glaucoma care -- high volume, high quality, low cost | Q42684196 | ||
| How nice is NICE? | Q43479683 | ||
| There is a trend for the diagnosis of glaucoma to be made at an earlier stage in 2010 compared to 2008 in Oxford, United Kingdom. | Q44121780 | ||
| Does telemedicine deserve the green light? | Q50493789 | ||
| Comparing costs of monitoring glaucoma patients: hospital ophthalmologists versus community optometrists. | Q50643110 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 779-783 | |
| P577 | publication date | 2014-07-01 | |
| P1433 | published in | Eye | Q10278937 |
| P1476 | title | Improving care and increasing efficiency-challenges in the care of chronic eye diseases | |
| P478 | volume | 28 |
| Q38955420 | A technician-delivered 'virtual clinic' for triaging low-risk glaucoma referrals |
| Q30882123 | Disease severity in newly diagnosed glaucoma patients with visual field loss: trends from more than a decade of data |
| Q36177066 | Experiences with developing and implementing a virtual clinic for glaucoma care in an NHS setting |
| Q35758009 | Improving the effectiveness of service delivery in the public healthcare sector: the case of ophthalmology services in Malaysia |
| Q36750380 | Measures of socioeconomic status and self-reported glaucoma in the U.K. Biobank cohort |
Search more.